Viewing Study NCT01865396



Ignite Creation Date: 2024-05-06 @ 1:40 AM
Last Modification Date: 2024-10-26 @ 11:07 AM
Study NCT ID: NCT01865396
Status: COMPLETED
Last Update Posted: 2021-12-01
First Post: 2013-05-24

Brief Title: Effect of Early Palliative Care on Quality of Life of Patients With Advanced Cancer a Randomised Controlled Trial
Sponsor: University Ghent
Organization: University Ghent

Study Overview

Official Title: Effect of Early Palliative Care on Quality of Life of Patients With Advanced Cancer a Randomised Controlled Trial
Status: COMPLETED
Status Verified Date: 2021-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: IPaC
Brief Summary: The World Health Organization WHO defines palliative care as an approach to improve the quality of life of patients and their families facing life-threatening illness through prevention and relief of pain and of physical psychosocial and spiritual problems The WHO stresses that palliative care is applicable early in the course of the illness together with other therapies that are intended to cure or prolong life such as chemotherapy or radiation therapy For the benefit of the patient palliative care is however often given too late in the course of the disease of incurably ill patients

The aim of our study is to measure the effect of interventional palliative care on quality of life mood and end-of-life care of patients with advanced cancer and their families These patients have a limited life expectancy and a high symptom burden this leads us to suggest that these patients may be benefited with palliative care soon after diagnosis of metastatic disease interventional palliative care

The research design of this study is a randomized controlled trial with on the one hand an intervention group in which patients and their families receive interventional palliative care in combination with standard cancer care and on the other hand a control group in which patients and their families receive only standard oncologic care Participants in the intervention group will meet the palliative support team shortly after diagnosis Afterwards the palliative support will meet them at least once a month This intervention focuses on topics such illness understanding symptom management decision making and coping with the disease Participants in the control group will only meet with the palliative support team at the patients own request or after referral by the oncologist or the nursing staff
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None